Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
GILD
GILEAD SCIENCES, INC.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$151.17
· 2026-10-09
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$184.82B
RECENT INSIDER TRADES
2026-10-02
· O'Day Daniel Patrick
(Chairman & CEO)
· SELL
2026-09-23
· Burkhart Erin
(SVP, Controllership)
· OTHER
2026-09-16
· Dickinson Andrew D
(Chief Financial Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
2,489
Shares held
1,370,756,256
Value
$159.18B
Percent of shares outstanding
110.55%
As of quarter end
2026-09-30
RECENT CONGRESSIONAL TRADES
2026-08-10
· Ro Khanna · SELL
· $1,001 - $15,000
2026-07-07
· Ro Khanna · SELL
· $1,001 - $15,000
2026-05-06
· Jared Moskowitz · BUY
· $1,001 - $15,000
2026-03-27
· Alan Armstrong · BUY
· $1,001 - $15,000
2026-01-27
· Hon. Josh Gottheimer · BUY
· $1,001 - $15,000
RECENT NEWS
Gilead: Buying Growth Isn't Free, And The Discounted Cash Flow Model Knows It
Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
Gilead: HIV Growth Is Not Enough At The Current Price
Why Morgan Stanley likes Gilead's HIV prevention play
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
GILEAD SCIENCES, INC. (GILD) · Stock Price, Insider Trades, Congress Trades · CatalystPit